ACBC Victoria is excited to continue our web series focussed on your health and cross-border medical collaboration and opportunities.
Are your eyes starting to hurt?
As a second wave of COVID-19 hits Victoria, working and managing relations continue to be almost exclusively via computers. Screens have become a necessity in all aspects of business and our eye health can easily be overlooked.
In the second edition of The Healthiest You series, we are pleased to host Professor Mingguang He (University of Melbourne/Centre for Eye Research Australia) and Professor Andrew Wilson (Chief Medical Officer, Safer Care Victoria) to speak on eye health, disease prevention and future technology and cross border collaboration in the sector.
Prof. He will also provide an update on his landmark study into the epidemic levels of short-sightedness – approximately 80-90% of high school graduates – in urban areas of East and Southeast Asia.
This session will also address:
During this COVID-19 period, it is important to look after your health. In ‘The Healthiest You’ series, Australian health and medical experts will address prevalent healthcare issues affecting our society and provide valuable advice on how to improve lives through preventative measures, adoption of healthier lifestyles and give advice on where to seek help in the health system.
Proudly supported by Swisse, this collaboration between the Australia China Business Council Victoria (ACBC Vic) and the Australia China Health Accelerator (ACHA) brings you a series of webinars to promote healthier living and holistic approaches to health, leveraging Victoria’s excellence in the health sector and medical research.
Professor Mingguang He – Professor of Ophthalmic Epidemiology, University of Melbourne.
He undertook his medical training in China, holds a Masters Degree in Public Health from Johns Hopkins University in Baltimore, and PhD in ophthalmology at Moorfields Eye Hospital in London.
Professor He is a global expert in vision-related clinical and epidemiologic research. He led several important population-based studies in China, including the first glaucoma survey and a large-scale twin study in China. He serves editorial board for several important journals, including Ophthalmology, PLoS One, Molecular Vision and APJO. He is currently the deputy secretary-general of Asia-Pacific Academy of Ophthalmology and a Board member of the Australia China Health Accelerator. His research interests include clinical and epidemiological research, randomized clinical trials, twin studies and imaging technology. His current research priority is big data, precision medicine and technology translational research.
Professor He has recently conducted a landmark study into myopia in young adults of East and Southeast Asia, which will be discussed during the session.
Professor Andrew Wilson – Chief Medical Officer, Safer Care Victoria
Spanning a successful career in clinical medicine, Andrew continues to practise as a cardiologist at St Vincent’s Health Melbourne, in the private sector and in rural Victoria. His clinical focus is on treatment and prevention of atherosclerosis. He has an academic appointment at the University of Melbourne and leads an active clinical research program supervising research students and fellows.
He previously worked at Stanford University Medical Centre where he was a NHMRC Research Fellow focusing on translational research in atherosclerosis.
As CMO of Safer Care Victoria (SCV), Andrew champions key SCV projects and provides expert advice to the CEO and the Department of Health and Human Services on quality and safety matters. He is a key contact point to escalate professional quality and safety matters and provides professional leadership to the sector. He is also Chair of the Australia China Health Accelerator.
We welcome all to join the launch of this impactful new series exploring opportunities for collaboration and building on already strong health and medical research links between Victoria and China.
Consumer demand in China remains strong in the healthcare sector, and Australia’s experience, skills and networks, through the China Australia Free Trade Agreement (ChAFTA) signed in 2015, mean there are practical pathways for Australian companies to develop and commercialise opportunities.
This event is proudly supported by:
and organised in collaboration with:
Date: Tuesday 11 August 2020
Time: 12:00pm – 1:00pm AEST
Format: Zoom Webinar, Presentation, Q&A
Cost: Free for ACBC Members and $35 General Admission (+GST +Online Booking Fee)